NASDAQ:BNGO Bionano Genomics Q3 2026 Earnings Date & Estimates $1.20 +0.04 (+3.02%) As of 02:51 PM Eastern This is a fair market value price provided by Massive. Learn more. Bionano Genomics is estimated to report Q3 2026 earnings on Tuesday, November 10, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 10, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Bionano Genomics in Q3 2026Bionano Genomics is expected to post earnings of -$0.45 per share on revenue of $8.44 million. In the same quarter a year earlier Bionano Genomics reported -$1.59 per share on revenue of $7.37 million. Bionano Genomics last reported on August 10, 2026, posting -$0.64 per share and beating the -$0.67 consensus estimate. Bionano Genomics has beaten the consensus EPS estimate in 6 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.45Expected Revenue$8.44 millionPrior-Year EPS-$1.59Prior-Year Revenue$7.37 millionExpected Revenue Growth+14.6%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.64 (Beat by +$0.03)Last Quarter Revenue-$6.67 millionEPS Beat Rate6 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Bionano Genomics Q3 2026 Earnings FAQ When does Bionano Genomics report Q3 2026 earnings? Bionano Genomics (NASDAQ:BNGO) is estimated to report Q3 2026 earnings on Tuesday, November 10, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Bionano Genomics' Q3 2026 earnings call? Bionano Genomics' Q3 2026 earnings conference call is scheduled for Tuesday, November 10, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Bionano Genomics? Analysts expect Bionano Genomics to post earnings of -$0.45 per share for Q3 2026. How much revenue is Bionano Genomics expected to report? The consensus revenue estimate for Bionano Genomics is $8.44 million for Q3 2026. Bionano Genomics Earnings HeadlinesContrasting Fortrea (NASDAQ:FTRE) and Bionano Genomics (NASDAQ:BNGO)November 1 at 2:31 AM | americanbankingnews.comBionano to Report Third Quarter 2026 Financial Results and Host a Conference Call Webcast on November 10, 2026October 27, 2026 | globenewswire.comBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the digital dollar. They gave us the timeline… 2025 to 2030. We're in that window right now. Once the digital dollar launches, every transaction you make will be tracked. Your spending could be controlled. Your accounts could be frozen. Over 4,500 investors have already used this legal backdoor to hold assets CBDCs can't freeze and generate yields the Federal Reserve can't touch.November 3 at 1:00 AM | Decentralized Masters (Ad)Bionano Genomics consensus price target lowered 11.11% to MX$89.76October 22, 2026 | msn.comBionano Genomics consensus price target increased by 21.14% to MX$100.98October 4, 2026 | msn.comBionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic MalignanciesSeptember 23, 2026 | globenewswire.comSee More Bionano Genomics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Bionano Genomics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bionano Genomics and other key companies, straight to your email. Email Address About Bionano GenomicsBionano Genomics (NASDAQ:BNGO) is a life sciences company that develops genomic analysis tools designed to help researchers and clinicians detect large-scale structural variations in DNA. Its technology is intended to complement or extend conventional sequencing and cytogenetic methods by providing information about changes in genome structure, including deletions, duplications, inversions and translocations. The company’s principal platform is the Saphyr system, an optical genome mapping solution that analyzes ultra-high-molecular-weight DNA. The platform combines specialized instrumentation, consumables and software to create detailed maps of genomes. Bionano also offers analysis and interpretation software, including tools associated with its BioDiscovery business, as well as workflow and data-analysis services for research, translational and clinical applications. Bionano’s products are used by academic institutions, research organizations, biopharmaceutical companies, hospitals and clinical laboratories in areas such as cancer research, constitutional genetics, reproductive health and rare-disease investigation. Founded in 2003 and headquartered in San Diego, California, the company has expanded its offerings through acquisitions, including BioDiscovery and Lineagen, to provide genomic data analysis and testing capabilities alongside its optical genome mapping technology.View Bionano Genomics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Palantir's $2.3 Billion Quarter Puts Its Premium Valuation to the TestRepublic Services Has the Momentum, But Waste Management Has Another AdvantageAre the Fears Around Alphabet’s Search Slowdown Warranted?Alphabet's Golden Dome Talks Could Open a New Market, But How Much Is at Stake?Streaming Success: Fox Corp Channels Tubi For Q1 Earnings BeatCheck Point's Turnaround Could Be Closer Than Investors ThinkTempus AI Surges on Earnings Beat, But Can the Rally Last? Upcoming Earnings McDonald's (11/4/2026)DoorDash (11/4/2026)MercadoLibre (11/4/2026)Cenovus Energy (11/4/2026)Aflac (11/4/2026)Allstate (11/4/2026)MetLife (11/4/2026)Manulife Financial (11/4/2026)Cencora (11/4/2026)CVS Health (11/4/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
